BUY Retractable Technologies, Inc. (RVP) – last $1.58; 2:43pm . RVP designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. The company offers VanishPoint safety needle products to prevent needlestick injuries and reuse. Its products include 1cc tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5cc, 3cc, 5cc, and 10cc VanishPoint syringes; the VanishPoint blood collection tube holder; autodisable syringe and the VanishPoint IV safety catheter; and a small diameter tube adapter. The company’s products also include Patient Safe syringe, which reduces the risk of infection resulting from IV contamination, as well as dental syringe, winged IV sets, and an autodisable syringe. It markets its products to healthcare providers, which include acute care hospitals, alternate care facilities, doctors? offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas. … BUY ON VERFDICT. “LITTLE ELM, Texas–(BUSINESS WIRE)–Retractable Technologies, Inc. (AMEX: RVP – News), a leading maker of safety needle devices, announced today that a Marshall, Texas, jury returned a verdict yesterday finding that all three patents asserted by Retractable Technologies, Inc. (“the “Company”) against Becton Dickinson and Company (“BD”) are valid and infringed. The jury also awarded damages to the Company in the amount of $5 million. The verdict, which can be appealed by either party, is directed against BD’s infringing Integra^® syringes. Retractable Technologies, Inc. manufactures and markets safety medical products, principally VanishPoint® automated retraction safety syringes and blood collection devices, that virtually eliminate healthcare worker exposure to accidental needlestick injuries. These revolutionary devices use a patented friction ring mechanism that causes the contaminated needle to retract automatically, a feature that is designed to prevent both accidental needlestick injury and device reuse. Retractable also manufactures and markets Patient Safe™ syringes that are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. Our products are distributed by various specialty and general line distributors. For more information on Retractable, visit our website at www.vanishpoint.com. … No SPM+Game Theory rating with EXIT POINT  not determined.